Tight, dynamic control of the affinity of integrin adhesion receptors for their extracellular ligands (integrin activation) is essential for the development and functioning of multicellular organisms. Integrin activation is controlled by intracellular signals that, through their action on integrin cytoplasmic domains, induce conformational changes in integrin extracellular domains, resulting in increased affinity for the ligand. Recent results indicate that the binding of talin, a major actin-binding protein, to integrin β tails represents a final common step in integrin activation pathways. The major integrin-binding site lies within the talin FERM (four-point-one, ezrin, radixin, moesin) domain, and binding occurs via a variant of the classical PTB domain (phosphotyrosine-binding domain)-NPxY interaction. Formation of this talin-integrin complex plays a critical role in integrin activation, since mutations, in either talin or integrin β tails, which disrupt complex formation, inhibit integrin activation. Furthermore, use of RNA interference to knockdown talin expression selectively reveals that talin is essential for integrin activation in response to physiological agonists. Thus the association of the cytoskeletal protein talin with integrin β cytoplasmic domains is a critical step during integrin activation, and regulation of this step may be a final common element in the signalling pathways that control integrin activation.
Introduction
Integrins are heterodimeric adhesion receptors formed by the non-covalent association of α and β subunits. Each subunit is a type I transmembrane glycoprotein with relatively large extracellular domains and, with the exception of the β4 subunit, a short cytoplasmic tail [1] . Humans contain 18 α and eight β subunits that combine to produce at least 24 different heterodimers, each of which can bind to a specific repertoire of cell-surface, extracellular-matrix or soluble protein ligands, thereby mediating cell-cell and cell-substratum adhesion.
Integrins also transmit signals into and out of cells, so regulating cell migration, differentiation, proliferation and death [1] .
Integrin ligand-binding activity is under tight spatial and temporal control in vivo. One important mechanism by which cells regulate integrin function is through a rapid, reversible control of integrin affinity for extracellular ligands, so-called integrin activation [2, 3] , defined here as the increase in monomeric affinity that accompanies alterations in integrin conformation. Integrin activation is essential for normal development, since it controls cell adhesion, migration and the assembly of an extracellular matrix [4, 5] . Integrin activation is also involved in thrombus formation, leucocyte trafficking, angiogenesis and tumour cell metastasis, and deregulated integrin activation disrupts embryonic development, contributes to neoplasia and impairs cardiac function and the immune response [1] [2] [3] . Thus cellular control 
Talin is a critical integrin-activating protein
Integrin cytoplasmic tails play central roles in regulating integrin activation. These, generally short, tails interact with a wide range of intracellular ligands that connect the receptors to signalling pathways and cytoskeletal networks [6] [7] [8] . A large body of evidence points to a major role for interactions of the β subunit tails in regulating integrin activation [2, 3] , although recent results also highlight potential interactions of the α tail [9] . Nonetheless, until recently, the identity of the critical tail-binding proteins involved in integrin activation was not clear.
Recent results indicate that talin, a major cytoskeletal actin-binding protein that binds to integrin β tails and colocalizes with activated integrins, plays a critical role in integrin activation [10] . Talin is an antiparallel homodimer of two approx. 270 kDa subunits, each consisting of an N-terminal, approx. 50 kDa globular head and an approx. 220 kDa, C-terminal rod [7] . Talin was the first cytoplasmic protein shown to bind integrins [11] , and binding to β1A, β1D, β2, β3 and β5 and weak binding to β7 integrin tails has now been demonstrated [7, 8] . The major integrin-binding site lies within the talin head [12] [13] [14] , although the rod also contains a lower-affinity integrin-binding site [12, 14] .
The first evidence that talin was involved in the control of integrin activation came from overexpression studies [12] ; the expression of fragments of talin containing the integrinbinding head, but not those lacking the head, led to the activation of αIIbβ3. Talin head-mediated activation of β2 integrins has also been reported very recently [15] .
Furthermore, αIIbβ3 activation is also induced by a 96-aminoacid fragment of talin head that contains the highaffinity integrin-binding site [16] .
More recently, small interfering RNA-mediated selective knockdown of talin expression in a variety of cell lines has revealed that talin is required for the cellular-energydependent changes in integrin conformation that lead to activation [10] . Talin knockdown leads to decreased activation of β1 and β3 integrins without decreasing integrin cellsurface expression levels. Furthermore, the requirement for talin cannot be bypassed by the expression of other putative integrin-activating proteins [10] . In platelets and their precursor cells, namely megakaryocytes, αIIbβ3 integrins are rapidly activated in response to extracellular stimuli such as ADP or PAR4 (protease activated receptor 4) agonists; however, in the absence of talin, megakaryocytes do not activate integrins in response to stimulation with these physiological agonists [10] . Thus talin is required for integrin activation by intracellular signalling pathways.
Consistent with this central role in integrin function, talin, similar to integrin, is necessary for normal development in mice [17] , Drosophila [18] and Caenorhabditis elegans [19] . In Drosophila and C. elegans, talin deficiency generates phenotypes similar to integrin deficiency, indicating that talin is required for normal integrin function in vivo. However, talin is also required to provide the initial connections between ligand-occupied integrins and the actin cytoskeleton and for reinforcement of those linkages [18, 20, 21] ; therefore talin regulates integrin function in several ways. The specific role of defective integrin activation in the phenotypes of talindeficient animals remains to be assessed.
Talin is required for integrin activation, binds to most integrin β tails and overexpression of the integrin-binding talin head results in the activation of β2 and β3 integrins [12, 15] , suggesting that formation of the integrin-talin complex may lead to activation. Sequence analysis identified a FERM domain (four-point-one, ezrin, radixin, moesin domain) within the talin head [7, 16] . FERM domains consist of a trefoil arrangement of three subdomains, F1, F2 and F3 [22] , and X-ray crystallography has confirmed the presence of F2 and F3 subdomains within the talin head [23] . FERM domains often mediate interactions with the cytoplasmic tails of transmembrane proteins and both the F2 and F3 subdomains of talin bind specifically to integrin β tails [16] . However, the 96-amino-acid F3 contains the high-affinity integrin-binding site and the expression of talin F3, but not F2 or other high-affinity β tail-binding proteins, activates αIIbβ3 [16] .
As in other FERM domains, the F3 subdomain is a sandwich of two orthogonal antiparallel β-sheets followed by an α-helix and resembles a PTB domain (phosphotyrosinebinding domain). PTB domains often recognize peptide ligands containing β turns formed by NPxY motifs [24] . NPxY motifs are highly conserved in integrin β tails, and mutations that disrupt this motif perturb β turn formation, inhibit talin binding and interfere with integrin activation [12, 16, 25, 26] . The crystal structure of talin F3, engaging residues 739-750 of the β3 tail, reveals classical features of PTB domain-ligand interactions; integrin residues D 740 TA 742 form a β strand that augments the β sheet of F3 and residues N 744 PLY 747 form a reverse turn with Y747 pointing into an acidic and hydrophobic pocket [23] . When bound to talin, a highly conserved integrin β tail tryptophan residue (β3 W739) occupies a pocket within the F3. Mutation of this tryptophan residue, of integrin residues involved in β turn formation, or of talin residues that contact the β tail, disrupts the talin-β3 interaction and inhibits integrin activation [10, 23] . The key sites mediating talin binding are well conserved in mammalian, avian, Drosophila and C. elegans integrin β tails, suggesting that the β3-talin structure represents a general integrin-activation complex. Thus talin binds integrin β tails via a variant of the classical PTB domain-NPxY interaction and this complex is required for integrin activation.
Mechanism of talin-mediated integrin activation
Membrane-proximal regions of the short α and β integrin cytoplasmic tails are well conserved and play critical roles in integrin activation. Deletion of the conserved α subunit membrane-proximal GFFKR sequence or of the membraneproximal region of the β tail constitutively activates integrins, whereas deletions that retain the membrane-proximal sequences do not [1] [2] [3] . Mutagenesis suggests that a salt bridge stabilizes the association of the αIIb and β3 membraneproximal regions and therefore maintains αIIbβ3 in a lowaffinity state [27] . Furthermore, forced association of the cytoplasmic regions of αLβ2 or αMβ2 blocks activation, whereas preventing their association activates integrins [15, 28] . Biochemical evidence for a low-affinity interaction between α and β tails has been obtained [29, 30] and, under certain conditions, an interaction between the membraneproximal portions of αIIb and β3 tail peptides can be detected by NMR [31] . These interactions are disrupted by activating mutations in the α subunit membrane-proximal region [31, 32] . FRET (fluorescence resonance energy transfer) between cyan fluorescent protein-and yellow fluorescent protein-fused αL and β2 provides additional, in vivo, evidence for α-β tail associations that are disrupted or rearranged after activation [15] .
The NMR spectrum of the membrane-proximal region of the β3 tail is perturbed after the binding of activating, but not non-activating, talin fragments, and the talin head prevents detection of a membrane-proximal interaction between αIIb and β3 tail peptides [23, 31, 33] . This is consistent with the disruption of a membrane-proximal α-β tail interaction during activation, and is probably due to direct talin interactions with the membrane-proximal residues [13] or to indirect conformational changes induced after the formation of the talin PTB domain-NPxY complex. FRET analysis also indicates that the talin head disrupts interactions between the cytoplasmic tails of αLβ2 [15] . Notably, tethering the αIIb tail parallel with the β3 tail inhibits the effect of talin on membrane-proximal residues [33] , and deletion of the α subunit membrane-proximal regions generates integrins that remain activated in the absence of talin or metabolic energy [10, 34] . Therefore a critical step during integrin activation involves the formation of a talin PTB domainNPxY complex, which probably leads to the disruption of an inhibitory α-β tail interaction.
Control of talin-integrin interactions
In ERM (ezrin, radixin, moesin) proteins, interactions of the FERM domain with the C-terminal portion of the molecule mask the ligand-binding sites [22] . This interaction is disrupted by ERM protein phosphorylation, Rho-dependent signalling pathways and PIP2 (phosphatidylinositol 4,5-bisphosphate). The talin head has 6-fold higher affinity for β3 when compared with intact talin; this suggests that the β3 tail-binding site is masked in intact talin [14] and the mechanisms regulating unmasking of the talin FERM may control integrin activation. Despite numerous reports on talin phosphorylation, the effects of these modifications are still not clear. On the other hand, PIP2 binding to talin induces a conformational change that unmasks the integrin-binding site within the talin FERM domain and enhances its association with integrin β1 tails [35] . Notably, talin binds to and activates one splice variant of the PIP2-producing enzyme PIPKIγ -90 (phosphatidylinositol phosphate kinase type Iγ -90) [21, 36] . Therefore talin can stimulate PIP2 production, which in turn enhances talin-integrin interactions, suggesting that PIPKIγ -90 may positively regulate integrin activation. However, PIPKIγ -90 and integrin β tails compete for overlapping binding sites on the talin F3 subdomain [36] ; therefore, under certain conditions, PIPKIγ -90 may inhibit integrin activation by displacing talin from β tails. The protease calpain, which cleaves between the talin head and rod [7, 12] , provides another mechanism for unmasking the integrin-binding site. Calpain cleavage increases talin binding to integrins in vitro [14] ; however, whether talin cleavage is sufficient to activate integrins in vivo remains to be tested. Calpain also cleaves integrin β tails [37] , providing a potential mechanism for subsequently down-regulating integrin activation.
PTB domains were initially characterized as domains that bind to phosphorylated tyrosine residues; however, their binding is often independent of phosphotyrosine [24] . Non-phosphorylated integrin tails bind to talin [12, 16] and tyrosine phosphorylation of the β tail NPxY motif inhibits talin binding [38] . Consistent with these observations, the side chain of β3 Y747 occupies an uncharged pocket in talin F3 [23] . Tyrosine phosphorylation of the NPxY motifs in integrin β tails by Src-family kinases decreases cell adhesion, leads to integrin displacement from focal adhesions and is important in cell migration and transformation [39] [40] [41] . These effects are consistent with disruption of integrintalin interactions and are reversed by the expression of non-phosphorylatable integrins [40, 41] . Therefore integrin phosphorylation by Src-family or other kinases is probably an important negative regulator of integrin activation.
Integrin activation is probably also inhibited by other β tail-binding proteins that compete with talin for sites on the β tail. Many other PTB domains also bind the NPxY motifs in integrin β tails [42] . One such protein, ICAP-1α (integrin cytoplasmic domain-associated protein 1α), binds to β1A through a PTB domain-NPxY interaction [43] and inhibits β1A-talin association [44] . These competitors may therefore inhibit integrin activation by preventing talin binding to integrin β tails. Furthermore, tyrosine phosphorylation of integrin β tails may influence this by favouring the binding of alternative PTB domain-containing proteins [42, 43] . It will be important to determine the roles of other integrinbinding PTB or FERM domains as positive or negative regulators of integrin activation and the role of integrin phosphorylation in determining PTB-domain-binding specificity.
Future directions
A central role for talin in controlling integrin activation, probably through effects on the membrane-proximal regions of the integrin β tails, has now been revealed. However, additional structural studies are needed to resolve how talin alters integrin membrane-proximal regions to propagate activation signals, and the pathways that regulate integrin-talin interactions require further elaboration. In addition to talin, at least three other β tail-binding proteins, β3-endonexin [45] , cytohesin [46] and CD98hc [47, 48] , and one α tail-binding protein CIB protein (calcium-and integrin-binding protein) [49] , have been implicated in directly regulating integrin activation. Whether these proteins represent special pathways that synergize with, or are alternatives to, talin-mediated integrin action is not yet known. However, talin is required for β3-endonexin-and CD98-mediated effects on β3 integrin activation in fibroblastic cells [10] . The importance of the talin PTB domain-NPxY interaction, along with observation that many PTB domains bind integrin β tails [42] , suggests that other integrin-binding PTB-or FERM-domain-containing proteins may activate integrins, although those tested to date [16, 50] do not activate αIIbβ3. Therefore the potential positive or negative effects of other tail-binding proteins and the role of other integrin-activating proteins and their interactions with talin all require further investigation.
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